Concordance of assays designed for the quantification of JAK2V617F

A multicenter study

Eric Lippert, François Girodon, Emma Hammond, Jaroslav Jelinek, N. Scott Reading, Boris Fehse, Katy Hanlon, Mirjam Hermans, Céline Richard, Sabina Swierczek, Valérie Ugo, Serge Carillo, Véronique Harrivel, Christophe Marzac, Daniela Pietra, Marta Sobas, Morgane Mounier, Marina Migeon, Sian Ellard, Nicolaus Kröger & 4 others Richard Herrmann, Josef T. Prchal, Radek C. Skoda, Sylvie Hermouet

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background: Many different techniques have been designed for the quantification of JAK2V617F allelic burden, sometimes producing discrepant results. Design and Methods: JAK2V617F quantification techniques were compared among 16 centers using 11 assays based on quantitative polymerase chain reaction (with mutation-specific primers or probes, or fluorescent resonance energy transfer/melting curve analysis), allele-specific polymerase chain reaction, conventional sequencing or pyrosequencing. Results: A first series of blinded samples (granulocyte DNA, n=29) was analyzed. Seven assays (12 centers) reported values inside the mean±2SD; the mean coefficient of variation was 31%. Sequencing techniques lacked sensitivity, and strong discrepancies were observed with four techniques, which could be attributed to inadequate standards or to different modes of expression of results. Indeed, quantification of JAK2V617F in relation to another control gene produced higher than expected values, suggesting the possibility of more than two JAK2 copies/cell. After calibration of assays with common 1% to 100% JAK2V617F standards (dilutions of UKE-1 cells in normal leukocytes), 14 centers tested ten new samples. JAK2V617F allelic burdens greater or equal than 1% were then reliably quantified by five techniques - one allele specific-polymerase chain reaction and four TaqMan allele-specific quantitative polymerase chain reaction assays, including one previously giving results outside the mean±2SD - with a lower mean coefficient of variation (21%). Of these, only the two TaqMan allele-specific quantitative polymerase chain reaction assays with primerbased specificity could detect 0.2% JAK2V617F. Conclusions: Techniques expressing the allelic burden as JAK2V617F/total JAK2 and using a common set of standards produced similar quantification results but with variable sensitivity. Calibration to a reference standard improved reproducibility.

Original languageEnglish
Pages (from-to)38-45
Number of pages8
JournalHaematologica
Volume94
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Multicenter Studies
Polymerase Chain Reaction
Alleles
Calibration
Energy Transfer
Fluorescent Dyes
Granulocytes
Freezing
Leukocytes
Mutation
DNA
Genes

Keywords

  • Allele-specific PCR
  • JAK2V617F
  • Multicenter stud
  • Myeloproliferative diseases
  • Quantification
  • Standardization

ASJC Scopus subject areas

  • Hematology

Cite this

Lippert, E., Girodon, F., Hammond, E., Jelinek, J., Reading, N. S., Fehse, B., ... Hermouet, S. (2009). Concordance of assays designed for the quantification of JAK2V617F: A multicenter study. Haematologica, 94(1), 38-45. https://doi.org/10.3324/haematol.13486

Concordance of assays designed for the quantification of JAK2V617F : A multicenter study. / Lippert, Eric; Girodon, François; Hammond, Emma; Jelinek, Jaroslav; Reading, N. Scott; Fehse, Boris; Hanlon, Katy; Hermans, Mirjam; Richard, Céline; Swierczek, Sabina; Ugo, Valérie; Carillo, Serge; Harrivel, Véronique; Marzac, Christophe; Pietra, Daniela; Sobas, Marta; Mounier, Morgane; Migeon, Marina; Ellard, Sian; Kröger, Nicolaus; Herrmann, Richard; Prchal, Josef T.; Skoda, Radek C.; Hermouet, Sylvie.

In: Haematologica, Vol. 94, No. 1, 01.2009, p. 38-45.

Research output: Contribution to journalArticle

Lippert, E, Girodon, F, Hammond, E, Jelinek, J, Reading, NS, Fehse, B, Hanlon, K, Hermans, M, Richard, C, Swierczek, S, Ugo, V, Carillo, S, Harrivel, V, Marzac, C, Pietra, D, Sobas, M, Mounier, M, Migeon, M, Ellard, S, Kröger, N, Herrmann, R, Prchal, JT, Skoda, RC & Hermouet, S 2009, 'Concordance of assays designed for the quantification of JAK2V617F: A multicenter study', Haematologica, vol. 94, no. 1, pp. 38-45. https://doi.org/10.3324/haematol.13486
Lippert E, Girodon F, Hammond E, Jelinek J, Reading NS, Fehse B et al. Concordance of assays designed for the quantification of JAK2V617F: A multicenter study. Haematologica. 2009 Jan;94(1):38-45. https://doi.org/10.3324/haematol.13486
Lippert, Eric ; Girodon, François ; Hammond, Emma ; Jelinek, Jaroslav ; Reading, N. Scott ; Fehse, Boris ; Hanlon, Katy ; Hermans, Mirjam ; Richard, Céline ; Swierczek, Sabina ; Ugo, Valérie ; Carillo, Serge ; Harrivel, Véronique ; Marzac, Christophe ; Pietra, Daniela ; Sobas, Marta ; Mounier, Morgane ; Migeon, Marina ; Ellard, Sian ; Kröger, Nicolaus ; Herrmann, Richard ; Prchal, Josef T. ; Skoda, Radek C. ; Hermouet, Sylvie. / Concordance of assays designed for the quantification of JAK2V617F : A multicenter study. In: Haematologica. 2009 ; Vol. 94, No. 1. pp. 38-45.
@article{9e28a27271964b62b543d9a1bd7738b8,
title = "Concordance of assays designed for the quantification of JAK2V617F: A multicenter study",
abstract = "Background: Many different techniques have been designed for the quantification of JAK2V617F allelic burden, sometimes producing discrepant results. Design and Methods: JAK2V617F quantification techniques were compared among 16 centers using 11 assays based on quantitative polymerase chain reaction (with mutation-specific primers or probes, or fluorescent resonance energy transfer/melting curve analysis), allele-specific polymerase chain reaction, conventional sequencing or pyrosequencing. Results: A first series of blinded samples (granulocyte DNA, n=29) was analyzed. Seven assays (12 centers) reported values inside the mean±2SD; the mean coefficient of variation was 31{\%}. Sequencing techniques lacked sensitivity, and strong discrepancies were observed with four techniques, which could be attributed to inadequate standards or to different modes of expression of results. Indeed, quantification of JAK2V617F in relation to another control gene produced higher than expected values, suggesting the possibility of more than two JAK2 copies/cell. After calibration of assays with common 1{\%} to 100{\%} JAK2V617F standards (dilutions of UKE-1 cells in normal leukocytes), 14 centers tested ten new samples. JAK2V617F allelic burdens greater or equal than 1{\%} were then reliably quantified by five techniques - one allele specific-polymerase chain reaction and four TaqMan allele-specific quantitative polymerase chain reaction assays, including one previously giving results outside the mean±2SD - with a lower mean coefficient of variation (21{\%}). Of these, only the two TaqMan allele-specific quantitative polymerase chain reaction assays with primerbased specificity could detect 0.2{\%} JAK2V617F. Conclusions: Techniques expressing the allelic burden as JAK2V617F/total JAK2 and using a common set of standards produced similar quantification results but with variable sensitivity. Calibration to a reference standard improved reproducibility.",
keywords = "Allele-specific PCR, JAK2V617F, Multicenter stud, Myeloproliferative diseases, Quantification, Standardization",
author = "Eric Lippert and Fran{\cc}ois Girodon and Emma Hammond and Jaroslav Jelinek and Reading, {N. Scott} and Boris Fehse and Katy Hanlon and Mirjam Hermans and C{\'e}line Richard and Sabina Swierczek and Val{\'e}rie Ugo and Serge Carillo and V{\'e}ronique Harrivel and Christophe Marzac and Daniela Pietra and Marta Sobas and Morgane Mounier and Marina Migeon and Sian Ellard and Nicolaus Kr{\"o}ger and Richard Herrmann and Prchal, {Josef T.} and Skoda, {Radek C.} and Sylvie Hermouet",
year = "2009",
month = "1",
doi = "10.3324/haematol.13486",
language = "English",
volume = "94",
pages = "38--45",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Concordance of assays designed for the quantification of JAK2V617F

T2 - A multicenter study

AU - Lippert, Eric

AU - Girodon, François

AU - Hammond, Emma

AU - Jelinek, Jaroslav

AU - Reading, N. Scott

AU - Fehse, Boris

AU - Hanlon, Katy

AU - Hermans, Mirjam

AU - Richard, Céline

AU - Swierczek, Sabina

AU - Ugo, Valérie

AU - Carillo, Serge

AU - Harrivel, Véronique

AU - Marzac, Christophe

AU - Pietra, Daniela

AU - Sobas, Marta

AU - Mounier, Morgane

AU - Migeon, Marina

AU - Ellard, Sian

AU - Kröger, Nicolaus

AU - Herrmann, Richard

AU - Prchal, Josef T.

AU - Skoda, Radek C.

AU - Hermouet, Sylvie

PY - 2009/1

Y1 - 2009/1

N2 - Background: Many different techniques have been designed for the quantification of JAK2V617F allelic burden, sometimes producing discrepant results. Design and Methods: JAK2V617F quantification techniques were compared among 16 centers using 11 assays based on quantitative polymerase chain reaction (with mutation-specific primers or probes, or fluorescent resonance energy transfer/melting curve analysis), allele-specific polymerase chain reaction, conventional sequencing or pyrosequencing. Results: A first series of blinded samples (granulocyte DNA, n=29) was analyzed. Seven assays (12 centers) reported values inside the mean±2SD; the mean coefficient of variation was 31%. Sequencing techniques lacked sensitivity, and strong discrepancies were observed with four techniques, which could be attributed to inadequate standards or to different modes of expression of results. Indeed, quantification of JAK2V617F in relation to another control gene produced higher than expected values, suggesting the possibility of more than two JAK2 copies/cell. After calibration of assays with common 1% to 100% JAK2V617F standards (dilutions of UKE-1 cells in normal leukocytes), 14 centers tested ten new samples. JAK2V617F allelic burdens greater or equal than 1% were then reliably quantified by five techniques - one allele specific-polymerase chain reaction and four TaqMan allele-specific quantitative polymerase chain reaction assays, including one previously giving results outside the mean±2SD - with a lower mean coefficient of variation (21%). Of these, only the two TaqMan allele-specific quantitative polymerase chain reaction assays with primerbased specificity could detect 0.2% JAK2V617F. Conclusions: Techniques expressing the allelic burden as JAK2V617F/total JAK2 and using a common set of standards produced similar quantification results but with variable sensitivity. Calibration to a reference standard improved reproducibility.

AB - Background: Many different techniques have been designed for the quantification of JAK2V617F allelic burden, sometimes producing discrepant results. Design and Methods: JAK2V617F quantification techniques were compared among 16 centers using 11 assays based on quantitative polymerase chain reaction (with mutation-specific primers or probes, or fluorescent resonance energy transfer/melting curve analysis), allele-specific polymerase chain reaction, conventional sequencing or pyrosequencing. Results: A first series of blinded samples (granulocyte DNA, n=29) was analyzed. Seven assays (12 centers) reported values inside the mean±2SD; the mean coefficient of variation was 31%. Sequencing techniques lacked sensitivity, and strong discrepancies were observed with four techniques, which could be attributed to inadequate standards or to different modes of expression of results. Indeed, quantification of JAK2V617F in relation to another control gene produced higher than expected values, suggesting the possibility of more than two JAK2 copies/cell. After calibration of assays with common 1% to 100% JAK2V617F standards (dilutions of UKE-1 cells in normal leukocytes), 14 centers tested ten new samples. JAK2V617F allelic burdens greater or equal than 1% were then reliably quantified by five techniques - one allele specific-polymerase chain reaction and four TaqMan allele-specific quantitative polymerase chain reaction assays, including one previously giving results outside the mean±2SD - with a lower mean coefficient of variation (21%). Of these, only the two TaqMan allele-specific quantitative polymerase chain reaction assays with primerbased specificity could detect 0.2% JAK2V617F. Conclusions: Techniques expressing the allelic burden as JAK2V617F/total JAK2 and using a common set of standards produced similar quantification results but with variable sensitivity. Calibration to a reference standard improved reproducibility.

KW - Allele-specific PCR

KW - JAK2V617F

KW - Multicenter stud

KW - Myeloproliferative diseases

KW - Quantification

KW - Standardization

UR - http://www.scopus.com/inward/record.url?scp=58149232434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149232434&partnerID=8YFLogxK

U2 - 10.3324/haematol.13486

DO - 10.3324/haematol.13486

M3 - Article

VL - 94

SP - 38

EP - 45

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -